Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-25-000832·Akero Therapeutics, Inc.
Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
COMMON STOCK · CUSIP: 00973Y108
Event date: 2025-09-30
- Filing-level shares
- 3,810,076
- Percent of class
- 4.8%
- T. Rowe Price Associates, Inc.
Shares: 3,810,076 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000832
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership